These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4331859)

  • 1. The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors.
    Nieto M; Perkins HR
    Biochem J; 1971 Oct; 124(5):845-52. PubMed ID: 4331859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.
    Perkins HR
    Biochem J; 1969 Jan; 111(2):195-205. PubMed ID: 5763787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 125I-labeled ristocetin binding to Micrococcus luteus cells by the peptides related to bacterial cell wall mucopeptide precursors: quantitative structure-activity relationships.
    Kim KH; Martin Y; Otis E; Mao J
    J Med Chem; 1989 Jan; 32(1):84-93. PubMed ID: 2909749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative affinity of vancomycin and ristocetin for cell walls and uridine diphosphate-N-acetylmuramyl pentapeptide.
    Best GK; Grastie MK; McConnell RD
    J Bacteriol; 1970 May; 102(2):476-82. PubMed ID: 4986761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.
    Nieto M; Perkins HR
    Biochem J; 1971 Aug; 123(5):789-803. PubMed ID: 5124386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homoserine and diaminobutyric acid in the mucopeptide-precursor-nucleotides and cell walls of some plant-pathogenic corynebacteria.
    Perkins HR
    Biochem J; 1971 Feb; 121(3):417-23. PubMed ID: 5119774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell wall of Bacillus licheniformis N.C.T.C. 6346. Composition of the mucopeptide component.
    Hughes RC
    Biochem J; 1968 Jan; 106(1):41-8. PubMed ID: 5721470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations.
    Nieto M; Perkins HR; Reynolds PE
    Biochem J; 1972 Jan; 126(1):139-49. PubMed ID: 4627581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the vancomycin inhibition of peptidoglycan synthesis by cell walls.
    Sinha RK; Neuhaus RC
    J Bacteriol; 1968 Aug; 96(2):374-82. PubMed ID: 5674051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the action of vancomycin and ristomycin on processes in Staphylococcus 209-K].
    Dormidoshina TA; Sazykin IuO
    Mikrobiologiia; 1969; 38(2):228-32. PubMed ID: 4310248
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation of complexes between some glycopeptide antibiotics and bacterial cell-wall analogues by electrospray- and capillary zone electrophoresis/electrospray-mass spectrometry.
    Hamdan M; Curcuruto O; Di Modugno E
    Rapid Commun Mass Spectrom; 1995; 9(10):883-7. PubMed ID: 7670152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The killing of bacteria by cell wall inhibitors.
    Rogers HJ
    Contrib Microbiol Immunol; 1973; 1():117-34. PubMed ID: 4805300
    [No Abstract]   [Full Text] [Related]  

  • 14. The cell wall of Bacillus licheniformis N.C.T.C. 6346. Isolation of low-molecular-weight fragments from the soluble mucopeptide.
    Hughes RC
    Biochem J; 1968 Jan; 106(1):49-59. PubMed ID: 5721471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVIDENCE FOR AN INITIAL ACCEPTOR OF UDP-NAC-MURAMYL-PENTAPEPTIDE IN THE SYNTHESIS OF BACTERIAL MUCOPEPTIDE.
    STRUVE WG; NEUHAUS FC
    Biochem Biophys Res Commun; 1965 Jan; 18():6-12. PubMed ID: 14265759
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemical basis for the action of the vancomycin group of antibiotics.
    Perkins HR; Nieto M
    Ann N Y Acad Sci; 1974 May; 235(0):348-63. PubMed ID: 4369274
    [No Abstract]   [Full Text] [Related]  

  • 17. Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus.
    Bordet C; Perkins HR
    Biochem J; 1970 Oct; 119(5):877-83. PubMed ID: 4250137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
    Rák K; Boda Z; Sztaricskai F
    Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of the polysaccharide and mucopeptide components of the cell wall of Lactobacillus casei.
    Hall EA; Knox KW
    Biochem J; 1965 Aug; 96(2):310-8. PubMed ID: 5837778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation of iodinated vancomycin and its distribution in bacteria treated with the antibiotic.
    Perkins HR; Nieto M
    Biochem J; 1970 Jan; 116(1):83-92. PubMed ID: 5411430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.